Description and Brand Names
Drug information provided by: IBM Micromedex
US Brand Name
Belzutifan is used to treat von Hippel-Lindau (VHL) disease in patients who need treatment for kidney cancer (renal cell carcinoma), brain and spinal cord tumors (CNS hemangioblastomas), or pancreatic cancer (pancreatic neuroendocrine tumor [pNET]) that do not require surgery right away.
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms: